Jump to content
SCLERO.ORG
Sclero Forums

Salivary gland epithelial cells (SGECs) from patients with Sjögren's syndrome (pSS) induce B-lymphocyte survival and activation.


Recommended Posts

Salivary gland epithelial cells (SGECs) from patients with Sjögren's syndrome (pSS) induce B-lymphocyte survival and activation.

 

SGECs from patients with pSS had better ability than those from controls to induce survival and activation of B lymphocytes. PubMed, Ann rheumatologist Dis, 2020 Nov;79(11):1468-1477. (Also see Sjögren's Syndrome Research and B Cells and T Cells)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Link to post
Share on other sites
  • Joelf unpinned this topic

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...